Table 1.
Demographic characteristics of included participants with NeuP.
| Patient | Sex | Age (yrs) | Diagnosis | Pain site | Pain side | Pain duration | Medication |
|---|---|---|---|---|---|---|---|
| 1 | M | 15.4 | PNP | lower leg | bilateral | >5 years | AD |
| 2 | M | 12.9 | PPSP | abdominal | bilateral | >5 years | SC, NB |
| 3 | M | 16.9 | PNP | lower leg | bilateral | >5 years | SC* |
| 4 | F | 12.7 | PNP | lower back | R | 2–5 years | AC, SC |
| 5 | M | 13.3 | PPSP | lower leg | bilateral | 2–5 years | AD, SC |
| 6 | F | 16.7 | PPSP | lower leg | R | 2–5 years | AD, SC, NB |
| 7 | M | 14.4 | PPSP | upper leg | R | >5 years | AC, opioid+, SC |
| 8 | M | 15.2 | PNP | lower leg | R | 2–5 years | AD, AC |
| 9 | F | 16.7 | PPSP | lower leg | R | 2–5 years | none |
| 10 | F | 17.4 | PPSP | lower leg | L | 2–5 years | opioid∧, SC |
| 11 | M | 11.6 | PNP | lower leg | R | 1–2 years | none |
| 12 | F | 16.6 | PPSP | chest | L | >5 years | SC |
| 13 | M | 15.5 | PNP | lower leg | bilateral | >5 years | AD |
| 14 | F | 16.9 | PPSP | lower leg | bilateral | 2–5 years | AC, AD |
| 15 | F | 16.5 | PNP | whole leg | L | 1–2 years | AC |
| 16 | M | 11.7 | PPSP | lower leg | L | >5 years | SC |
| 17 | M | 15.9 | PPSP | lower leg | L | 1–2 years | none |
Medication includes only regular medication taken currently and excludes paracetamol and NSAIDs. The category “PNP” includes distal neuropathic symptoms and localized nerve lesion/injury. AC, anticonvulsant; AD, antidepressant; PNP, peripheral neuropathic pain; PPSP, persistent post-surgical pain; NB, nerve block; NeuP, neuropathic pain; opioid+, postoperative weaning morphine; opioid∧, PRN tramadol; SC, sodium channel blockers (lidocaine patch); SC*, oral mexiletine.